Boom: TAVR Low-Risk Trials Usher in a New Era in Cardiology Boom: TAVR Low-Risk Trials Usher in a New Era in Cardiology

The results are impressive for transcatheter aortic valve replacement in low-surgical-risk patients, but longer-term data on durability will be crucial, notes John Mandrola, MD.theheart.org on Medscape
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Expert Column Source Type: news